Secondary |
Pain |
18.7% |
Drug Use For Unknown Indication |
10.1% |
Product Used For Unknown Indication |
8.0% |
Nausea |
7.4% |
Cancer Pain |
6.4% |
Prophylaxis |
6.1% |
Spinal Column Stenosis |
4.9% |
Colorectal Cancer Metastatic |
4.3% |
Rheumatoid Arthritis |
4.0% |
Chronic Myeloid Leukaemia |
3.1% |
Constipation Prophylaxis |
3.1% |
Dizziness |
3.1% |
Hyperuricaemia |
3.1% |
Lumbar Spinal Stenosis |
3.1% |
Hepatic Neoplasm Malignant |
2.8% |
Constipation |
2.5% |
Metastases To Bone |
2.5% |
Periarthritis |
2.5% |
Restlessness |
2.5% |
Analgesia |
2.1% |
|
Systemic Inflammatory Response Syndrome |
10.9% |
Toxic Epidermal Necrolysis |
9.1% |
Vomiting |
9.1% |
Rash |
7.3% |
Malaise |
5.5% |
Off Label Use |
5.5% |
Somnolence |
5.5% |
Thrombocytopenia |
5.5% |
Treatment Noncompliance |
5.5% |
White Blood Cell Count Decreased |
5.5% |
Condition Aggravated |
3.6% |
Dizziness |
3.6% |
Gait Disturbance |
3.6% |
Hepatic Function Abnormal |
3.6% |
Inappropriate Schedule Of Drug Administration |
3.6% |
Nausea |
3.6% |
Salivary Hypersecretion |
3.6% |
Back Pain |
1.8% |
Dehydration |
1.8% |
Headache |
1.8% |
|
Concomitant |
Prophylaxis |
15.4% |
Cancer Pain |
13.2% |
Pain |
9.3% |
Product Used For Unknown Indication |
7.9% |
Drug Use For Unknown Indication |
7.3% |
Constipation |
7.2% |
Nausea |
5.4% |
Hypertension |
4.5% |
Metastatic Renal Cell Carcinoma |
4.0% |
Insomnia |
3.6% |
Renal Cell Carcinoma |
3.2% |
Multiple Myeloma |
3.0% |
Prophylaxis Of Nausea And Vomiting |
2.8% |
Breast Cancer |
2.5% |
Metastases To Bone |
2.4% |
Gastritis Prophylaxis |
1.9% |
Prostate Cancer Stage Iv |
1.8% |
Gastritis |
1.7% |
Chemotherapy |
1.5% |
Pleural Mesothelioma Malignant |
1.5% |
|
White Blood Cell Count Decreased |
14.4% |
Vomiting |
10.1% |
Pyrexia |
9.7% |
Platelet Count Decreased |
6.1% |
Pneumonia |
6.1% |
Renal Impairment |
5.9% |
Interstitial Lung Disease |
5.7% |
Renal Cell Carcinoma |
4.2% |
Somnolence |
4.2% |
Nausea |
4.0% |
Wrong Technique In Drug Usage Process |
4.0% |
Prostate Cancer |
3.4% |
Malignant Neoplasm Progression |
3.2% |
Thrombocytopenia |
3.2% |
Liver Disorder |
3.0% |
Tumour Lysis Syndrome |
3.0% |
Sepsis |
2.5% |
Stomatitis |
2.5% |
Pain |
2.3% |
Pneumonia Aspiration |
2.3% |
|
Interacting |
Hypertension |
40.0% |
Hyperlipidaemia |
20.0% |
Pyrexia |
20.0% |
Upper Respiratory Tract Infection |
20.0% |
|
Upper Respiratory Tract Infection |
100.0% |
|